Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Gray matter differences in patients with functional movement disorders.

Maurer CW, LaFaver K, Limachia GS, Capitan G, Ameli R, Sinclair S, Epstein SA, Hallett M, Horovitz SG.

Neurology. 2018 Oct 10. pii: 10.1212/WNL.0000000000006514. doi: 10.1212/WNL.0000000000006514. [Epub ahead of print]

PMID:
30305450
2.

Age and sex differences in burnout, career satisfaction, and well-being in US neurologists.

LaFaver K, Miyasaki JM, Keran CM, Rheaume C, Gulya L, Levin KH, Jones EC, Schwarz HB, Molano JR, Hessler A, Singhal D, Shanafelt TD, Sloan JA, Novotny PJ, Cascino TL, Busis NA.

Neurology. 2018 Oct 10. pii: 10.1212/WNL.0000000000006497. doi: 10.1212/WNL.0000000000006497. [Epub ahead of print]

PMID:
30305448
3.

Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders.

Espay AJ, Aybek S, Carson A, Edwards MJ, Goldstein LH, Hallett M, LaFaver K, LaFrance WC Jr, Lang AE, Nicholson T, Nielsen G, Reuber M, Voon V, Stone J, Morgante F.

JAMA Neurol. 2018 Sep 1;75(9):1132-1141. doi: 10.1001/jamaneurol.2018.1264.

PMID:
29868890
4.

Motor Retraining (MoRe) for Functional Movement Disorders: Outcomes From a 1-Week Multidisciplinary Rehabilitation Program.

Jacob AE, Kaelin DL, Roach AR, Ziegler CH, LaFaver K.

PM R. 2018 May 18. pii: S1934-1482(18)30245-4. doi: 10.1016/j.pmrj.2018.05.011. [Epub ahead of print]

PMID:
29783067
5.

Functional neurological disorders in Parkinson disease.

Wissel BD, Dwivedi AK, Merola A, Chin D, Jacob C, Duker AP, Vaughan JE, Lovera L, LaFaver K, Levy A, Lang AE, Morgante F, Nirenberg MJ, Stephen C, Sharma N, Romagnolo A, Lopiano L, Balint B, Yu XX, Bhatia KP, Espay AJ.

J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):566-571. doi: 10.1136/jnnp-2017-317378. Epub 2018 Mar 16.

PMID:
29549192
6.

Multidisciplinary clinic for functional movement disorders (FMD): 1-year experience from a single centre.

Jacob AE, Smith CA, Jablonski ME, Roach AR, Paper KM, Kaelin DL, Stretz-Thurmond D, LaFaver K.

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):1011-1012. doi: 10.1136/jnnp-2017-316523. Epub 2017 Nov 15. No abstract available.

PMID:
29142139
7.

Bridging the Gaps in Patient Education for DBS Surgery in Parkinson's Disease.

Knoop CD, Kadish R, Hager K, Park MC, Loprinzi PD, LaFaver K.

Parkinsons Dis. 2017;2017:9360354. doi: 10.1155/2017/9360354. Epub 2017 Aug 7.

8.

Personality traits in psychogenic nonepileptic seizures (PNES) and psychogenic movement disorder (PMD): Neuroticism and perfectionism.

Ekanayake V, Kranick S, LaFaver K, Naz A, Frank Webb A, LaFrance WC Jr, Hallett M, Voon V.

J Psychosom Res. 2017 Jun;97:23-29. doi: 10.1016/j.jpsychores.2017.03.018. Epub 2017 Mar 27.

9.

Diagnosis and Treatment of Functional (Psychogenic) Parkinsonism.

LaFaver K, Espay AJ.

Semin Neurol. 2017 Apr;37(2):228-232. doi: 10.1055/s-0037-1601487. Epub 2017 May 16. Review.

PMID:
28511263
10.

Inpatient treatment for functional neurologic disorders.

Williams DT, Lafaver K, Carson A, Fahn S.

Handb Clin Neurol. 2016;139:631-641. doi: 10.1016/B978-0-12-801772-2.00051-5. Review.

PMID:
27719878
11.

Impaired self-agency in functional movement disorders: A resting-state fMRI study.

Maurer CW, LaFaver K, Ameli R, Epstein SA, Hallett M, Horovitz SG.

Neurology. 2016 Aug 9;87(6):564-70. doi: 10.1212/WNL.0000000000002940. Epub 2016 Jul 6.

12.

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

Huntington Study Group, Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F Jr, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Chouinard S, Beland M, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E.

JAMA. 2016 Jul 5;316(1):40-50. doi: 10.1001/jama.2016.8655.

13.

Insights into Chronic Functional Movement Disorders: The Value of Qualitative Psychiatric Interviews.

Epstein SA, Maurer CW, LaFaver K, Ameli R, Sinclair S, Hallett M.

Psychosomatics. 2016 Nov - Dec;57(6):566-575. doi: 10.1016/j.psym.2016.04.005. Epub 2016 Apr 29.

14.

Impaired resting vagal tone in patients with functional movement disorders.

Maurer CW, Liu VD, LaFaver K, Ameli R, Wu T, Toledo R, Epstein SA, Hallett M.

Parkinsonism Relat Disord. 2016 Sep;30:18-22. doi: 10.1016/j.parkreldis.2016.06.009. Epub 2016 Jun 16.

15.

Clinical Reasoning: A 28-year-old woman with lower extremity spasticity and microcytic anemia.

Bonda C, Sharma P, LaFaver K.

Neurology. 2015 Jul 14;85(2):e11-4. doi: 10.1212/WNL.0000000000001736. No abstract available.

PMID:
26170404
16.

A biological measure of stress levels in patients with functional movement disorders.

Maurer CW, LaFaver K, Ameli R, Toledo R, Hallett M.

Parkinsonism Relat Disord. 2015 Sep;21(9):1072-5. doi: 10.1016/j.parkreldis.2015.06.017. Epub 2015 Jun 21.

17.

Functional or psychogenic: what's the better name?

LaFaver K, Hallett M.

Mov Disord. 2014 Nov;29(13):1698-9. doi: 10.1002/mds.26035. Epub 2014 Sep 21. No abstract available.

18.

The "floating door sign" in Parkinson's disease.

Kulkarni O, Lafaver K, Tarsy D.

Parkinsonism Relat Disord. 2013 Sep;19(9):825-6. doi: 10.1016/j.parkreldis.2013.04.013. Epub 2013 May 7.

PMID:
23660546
19.

Loss of benefit in VIM thalamic deep brain stimulation (DBS) for essential tremor (ET): how prevalent is it?

Shih LC, LaFaver K, Lim C, Papavassiliou E, Tarsy D.

Parkinsonism Relat Disord. 2013 Jul;19(7):676-9. doi: 10.1016/j.parkreldis.2013.03.006. Epub 2013 Apr 11.

PMID:
23582712
20.

Action-effect binding is decreased in motor conversion disorder: implications for sense of agency.

Kranick SM, Moore JW, Yusuf N, Martinez VT, LaFaver K, Edwards MJ, Mehta AR, Collins P, Harrison NA, Haggard P, Hallett M, Voon V.

Mov Disord. 2013 Jul;28(8):1110-6. doi: 10.1002/mds.25408. Epub 2013 Mar 14.

21.

Thalamic and subthalamic deep brain stimulation for parkinsonian tremor: are two circuits involved?

Kulkarni O, Lafaver K, Papavassiliou E, Tarsy D, Shih LC.

Mov Disord. 2013 Apr;28(4):554-5. doi: 10.1002/mds.25299. Epub 2013 Feb 6. No abstract available.

PMID:
23389961

Supplemental Content

Loading ...
Support Center